TABLE E-3 Section 317, VFC, and State Immunization Spending (dollars in millions [dollar per birth cohort member])

 

Vaccine Purchase

 

317 DA 1995

317 DA 1998

VFC DA 1995

VFC DA 1998

State Revs 1995

State Revs 1998

Maine

0.682

1.883

1.26

1.592

included in infrastructure

($/birth cohort)

[47.23

137.76

87.25

 

116.47]

 

New Jersey

1.673

1.916

2.654

3.259

0.02

0.02

 

[14.24

16.91

22.59

28.77

0.17

0.18]

North Carolina

1.985

3.154

4.129

10.92

7.875

10.737

 

[19.57

29.47

40.71

102.04

77.65

100.33]

Alabama

3.54

2.265

4.941

7.06

1

0.4

 

[58.09

37.18

81.08

115.9

16.41

6.57]

Michigan

4.987

10.463

9.071

12.742

3.911

0.101

 

[36.13

78.25

65.72

95.29

28.33

0.76]

Texas

6.476

9.098

28.023

34.524

19.863

13.731

[20.17

27.24

87.27

103.37

61.86

41.11]

Washington

2.512

3.266

3.106

6.008

3.534

7.082

 

[32.47

41.77

40.15

76.84

45.68

90.57]

California

6.987

9.241

51.319

72.555

 

 

[13.31

17.61

97.78

138.24]

 

Los Angeles

 

0.099

 

[0.57]

San Diego

 

0.05

 

[1.11]

National

96.304

135.562

247.692

399.974

 

 

[24.36

34.93

62.65

103.06]

 

NOTE: Los Angeles and San Diego include county as well as state spending. Texas includes separate 317 grants to Houston and San Antonio.

SOURCES: CDC, National Immunization program data for 317 and VFC. IOM case study data for state and local immunization spending. 1994 and 1997 birth cohorts: National Center for Health Statistics, Vital Health Statistics.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement